Demonstration of a novel Xp22.2 microdeletion as the cause of familial extreme skewing of X‐inactivation utilizing case‐parent trio SNP microarray analysis. Issue 3 (28th February 2018)

• Record Type: Journal Article
• Authors: Mason, Jane A.; Aung, Hnin T.; Nandini, Adayapalam; Woods, Rickie G.; Fairbairn, David J.; Rowell, John A.; Young, David; Susman, Rachel D.; Brown, Simon A.; Hyland, Valentine J.; Robertson, Jeremy D.
• Is Part Of: Molecular genetics & genomic medicine. Volume 6:Issue 3(2018)
• Page Start: 357
• Page End: 369
• Publication Date: 2018-02-28
• Subjects: female -- genetics -- hemophilia -- pediatric -- X inactivation; Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.378
• Languages: English
• ISSNs: 2324-9269

Abstract

Abstract: Background: We report a kindred referred for molecular investigation of severe hemophilia A in a young female in which extremely skewed X‐inactivation was observed in both the proband and her clinically normal mother. Methods: Bidirectional Sanger sequencing of all F8 gene coding regions and exon/intron boundaries was undertaken. Methylation‐sensitive restriction enzymes were utilized to investigate skewed X‐inactivation using both a classical human androgen receptor (HUMARA) assay, and a novel method targeting differential methylation patterns in multiple informative X‐chromosome SNPs. Illumina Whole‐Genome Infinium microarray analysis was performed in the case‐parent trio (proband and both parents), and the proband's maternal grandmother. Results: The proband was a cytogenetically normal female with severe hemophilia A resulting from a heterozygous F8 pathogenic variant inherited from her similarly affected father. No F8 mutation was identified in the proband's mother, however, both the proband and her mother both demonstrated completely skewed X‐chromosome inactivation (100%) in association with a previously unreported 2.3 Mb deletion at Xp22.2. At least three disease‐associated genes ( FANCB, AP1S2, and PIGA ) were contained within the deleted region. Conclusions: We hypothesize that true "extreme" skewing of X‐inactivation (≥95%) is a rare occurrence, but when defined correctly there is a high probability of finding an X‐chromosome disease‐causing variant or larger deletion resulting in X‐inactivation through a survival disadvantage or cell lethal mechanism. We postulate that the 2.3 Mb Xp22.2 deletion identified in our kindred arose de novo in the proband's mother (on the grandfather's homolog), and produced extreme skewing of X‐inactivation via a "cell lethal" mechanism. We introduce a novel multitarget approach for X‐inactivation analysis using multiple informative differentially methylated SNPs, as an alternative to the classical single locus (HUMARA) method. We propose that for females with unexplained severe phenotypic expression of an X‐linked recessive disorder trio‐SNP microarray should be undertaken in combination with X‐inactivation analysis. Abstract : We report a kindred referred for molecular investigation of severe hemophilia A in a young female in which extremely skewed X‐inactivation was observed in both the proband and her clinically normal mother. No F8 mutation was identified in the proband's mother, however both the proband and her mother demonstrated completely skewed X‐chromosome inactivation in association with a previously unreported 2.3 Mb deletion at Xp22.2